Current status and prospects of clinical research on diagnosis and treatment of gastric cancer in China
10.3760/cma.j.issn.1671-0274.2020.02.003
- VernacularTitle: 我国胃癌诊治临床研究现状与展望
- Author:
Huimian XU
1
;
Xin WANG
Author Information
1. Department of Gastrointestinal Oncology, The First Affiliated Hospital, China Medical University, Shenyang 110001, China
- Publication Type:Editorial
- Keywords:
Gastric neoplasms;
Esophagogastric junction neoplasms;
Clinical research;
Real-world research
- From:
Chinese Journal of Gastrointestinal Surgery
2020;23(2):109-114
- CountryChina
- Language:Chinese
-
Abstract:
As early as in the 1960s, China has begun to conduct exploratory clinical researches on gastric cancer. In the past 10 years, the research projects have increased significantly. Among them, the minimally invasive surgery represented by laparoscopy (CLASS Trial), the hot spot of the esophagogastric junction cancer (5010 Trial), the perioperative adjuvant treatment of advanced gastric cancer (CGOG1001 and RESOLVE Trials), the conversion treatment of late gastric cancer (DRAGON Trial) and high quality clinical research such as real-world research based on large database have made great progress. But there are still many deficiencies, such as few multi-center prospective research, limited research return, and the quality and innovation of scientific research data need to be further improved. However, it should also be noted that the clinical researches of gastric cancer in China have greater advantages and development space. The characteristics of large population base, rich cases and large proportion of advanced gastric cancer are conducive to real-world research. In the future, we should follow the international frontier and combine with national conditions to deepen clinical research, so that more "Chinese elements" can be introduced into the international guidelines for gastric cancer, and promote the overall level of diagnosis and treatment of gastric cancer in China.
